Shares of W.R. Berkley Corporation WRB closed at $75.84 on Monday, near its 52-week high of $78.48. This proximity underscores investor confidence. It has the ingredients for further price appreciation.
The stock is trading above the 50-day and 200-day simple moving averages (SMA) of $74.42 and $69.91, respectively, indicating solid upward momentum. SMA is a widely used technical analysis tool to predict future price trends by analyzing historical price data.

Earnings of W.R. Berkley grew 27.8% in the last five years, better than the industry average of 21.6%. WRB has a solid surprise history. The insurer has a solid track record of beating earnings estimates in three of the last four quarters, while matching in one, the average being 6.24%.
Shares of W.R. Berkley have gained 25.6% in the past year, outperforming its industry, the Finance sector and the Zacks S&P 500 composite’s growth of 4.7%, 10.3% and 14.4%, respectively.

The Zacks Consensus Estimate for W.R. Berkley’s 2025 earnings per share indicates a year-over-year increase of 2.9%. The consensus estimate for revenues is pegged at $14.63 billion, implying a year-over-year improvement of 8.2%.
The consensus estimate for 2026 earnings per share and revenues indicates an increase of 9.6% and 4.8%, respectively, from the corresponding 2025 estimates.
Return on equity for the trailing 12 months was 18.8%, which compared favorably with the industry’s 8%. This reflects its efficiency in utilizing shareholders’ funds.
Also, return on invested capital (ROIC) has been increasing over the last few quarters while the company raised its capital investment over the same time frame. This reflects WRB’s efficiency in utilizing funds to generate income. ROIC in the trailing 12 months was 9.7%, better than the industry average of 6.1%.
Based on short-term price targets offered by 16 analysts, the Zacks average price target is $76.25 per share. The average suggests a potential 1.7% upside from the last closing price.

WRB shares are trading at a premium to the industry. Its price-to-book value of 2.94X is higher than the industry average of 1.43X.
Other insurers, such as Arch Capital Group Ltd. ACGL, The Travelers Companies, Inc. TRV and Cincinnati Financial Corporation CINF, are also trading at a premium to the industry.
As part of its growth strategy, WRB has been focusing on commercial lines, including excess and surplus lines, admitted lines, and specialty personal lines, where it also has a competitive advantage.
WRB’s insurance business, which contributes the lion’s share to net premium written, is poised to grow on the strength of several new startup units in varied business lines, expansion of international business that offers diversification benefits, rate increase, market dislocations, and high retention.
W.R. Berkley remains focused on expanding selectively in attractive global markets and thus has operations in the emerging markets of the United Kingdom, Continental Europe, South America, Canada, Scandinavia, Asia, and Australia.
WRB boasts more than 60 straight quarters of favorable reserve development, given its prudent underwriting. Operational excellence supports it in maintaining a solid balance sheet with sufficient liquidity and strong cash flows.
The property and casualty insurer is set to grow on rate increases, reserving discipline, diversification benefits, momentum in international business, investment in alternative assets, and consistent cash flow.
Banking on consistent cash flow, W.R. Berkley has been hiking dividends since 2005, as well as paying special dividends apart from buying back shares. Its dividend yield of 0.4% appears attractive compared with the industry average of 0.2%, making it an attractive pick for yield-seeking investors.
Given the premium valuation, it is better to stay cautious about this Zacks Rank #3 (Hold) stock. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| Sep-10 | |
| Sep-10 | |
| Sep-02 | |
| Sep-02 | |
| Aug-28 | |
| Aug-24 | |
| Aug-21 | |
| Aug-18 | |
| Aug-18 | |
| Aug-11 | |
| Aug-06 | |
| Aug-06 | |
| Aug-04 | |
| Jul-30 | |
| Jul-29 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite